Piette W W
J Am Acad Dermatol. 1987 Apr;16(4):855-61. doi: 10.1016/s0190-9622(87)70112-1.
There is strong evidence linking Kaposi's sarcoma with an increased risk of developing a second primary malignancy. This risk of a second malignancy appears to depend in part on the clinical setting in which Kaposi's sarcoma develops. This paper examines these risks by relating them to specific subsets of Kaposi's sarcoma and to specific types of second malignancies.
有确凿证据表明卡波西肉瘤与发生第二种原发性恶性肿瘤的风险增加有关。第二种恶性肿瘤的这种风险似乎部分取决于卡波西肉瘤发生的临床背景。本文通过将这些风险与卡波西肉瘤的特定亚组以及特定类型的第二种恶性肿瘤相关联来研究这些风险。